These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8909848)

  • 1. Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus.
    Pedneault L; Lapointe N; Alfieri C; Ghadirian P; Carpentier L; Samson J; Joncas J
    Clin Infect Dis; 1996 Oct; 23(4):806-8. PubMed ID: 8909848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.
    Riddler SA; Breinig MC; McKnight JL
    Blood; 1994 Aug; 84(3):972-84. PubMed ID: 8043879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.
    Henle W; Henle G; Andersson J; Ernberg I; Klein G; Horwitz CA; Marklund G; Rymo L; Wellinder C; Straus SE
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):570-4. PubMed ID: 3025881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection.
    Debyser Z; Reynders M; Goubau P; Desmyter J
    Clin Diagn Virol; 1997 May; 8(1):71-81. PubMed ID: 9248660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
    Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
    J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.
    Jenson H; McIntosh K; Pitt J; Husak S; Tan M; Bryson Y; Easley K; Shearer W
    J Infect Dis; 1999 Jun; 179(6):1395-404. PubMed ID: 10228060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothers.
    Pedneault L; Lapointe N; Alfieri C; Ghadirian P; Carpentier L; Samson J; Joncas J
    J Infect Dis; 1998 Apr; 177(4):1087-90. PubMed ID: 9534989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus DNA in the blood of infants, young children, and adults by age and HIV status.
    Brandt CD; Sison AV; Rakusan TA; Saxena ES; Kaufman TE; O'Donnell RM; Sever JL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):69-72. PubMed ID: 9436761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
    Fogg MH; Kaur A; Cho YG; Wang F
    J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
    Cortese M; Leng Y; Bjornevik K; Mitchell M; Healy BC; Mina MJ; Mancuso JD; Niebuhr DW; Munger KL; Elledge SJ; Ascherio A
    JAMA Neurol; 2024 May; 81(5):515-524. PubMed ID: 38497939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC; Ma J; Lin LS; Chi KH; Yen SH; Liu SM; Liu WT; Chen WK; Chang TH; Chen KY
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents.
    Fujieda M; Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
    Acta Paediatr Jpn; 1993 Oct; 35(5):394-9. PubMed ID: 8256622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection in HIV-positive patients.
    Telenti A; Uehlinger DE; Marchesi F; Germann D; Malinverni R; Matter L
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):601-9. PubMed ID: 7901016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor specific Epstein-Barr virus infection is not associated with leiomyosarcoma in human immunodeficiency virus negative individuals.
    Hill MA; Araya JC; Eckert MW; Gillespie AT; Hunt JD; Levine EA
    Cancer; 1997 Jul; 80(2):204-10. PubMed ID: 9217031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.